BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12759615)

  • 21. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P; Vergote I
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemoprevention of breast cancer: a hope justified?].
    Buser K; Delaloye JF
    Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
    Ricart JJ
    Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The STAR (Study of Tamoxifen and Raloxifene) trial in West Virginia.
    Jubelirer SJ; Crowell EB
    W V Med J; 2000; 96(6):602-4. PubMed ID: 11194089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention of breast cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
    [No Abstract]   [Full Text] [Related]  

  • 27. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 29. Summaries for patients. Using medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2013 Nov; 159(10):I-28. PubMed ID: 24400336
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
    Dunn BK; Ford LG
    Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NICE recommends preventive drugs for breast cancer.
    Wise J
    BMJ; 2013 Jun; 346():f4116. PubMed ID: 23801701
    [No Abstract]   [Full Text] [Related]  

  • 32. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 33. SERMs: meeting the promise of multifunctional medicines.
    Jordan VC
    J Natl Cancer Inst; 2007 Mar; 99(5):350-6. PubMed ID: 17341726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB
    J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two good choices to prevent breast cancer: great taste, less filling.
    Hortobagyi GN; Brown PH
    Cancer Prev Res (Phila); 2010 Jun; 3(6):681-5. PubMed ID: 20522797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lowering your breast cancer risk. A daily pill can hold the key to prevention for some women.
    Johns Hopkins Med Lett Health After 50; 2014 Feb; 25(15):1-2. PubMed ID: 25118364
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of raloxifene on other organs without bone: uterus].
    Nozaki M
    Clin Calcium; 2004 Oct; 14(10):55-60. PubMed ID: 15577132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rise of raloxifene and the fall of invasive breast cancer.
    Jordan VC
    J Natl Cancer Inst; 2008 Jun; 100(12):831-3. PubMed ID: 18544739
    [No Abstract]   [Full Text] [Related]  

  • 39. Defining the role of raloxifene for the prevention of breast cancer.
    Kalidas M; Hilsenbeck S; Brown P
    J Natl Cancer Inst; 2004 Dec; 96(23):1731-3. PubMed ID: 15572750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Breast cancer chemoprevention (tamoxifen, raloxifene, and others)].
    Funahashi H
    Nihon Rinsho; 2000 Apr; 58 Suppl():587-91. PubMed ID: 11026055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.